Medtronic (MDT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Medtronic sells products in many end markets in these segments ... The firm faced an FDA warning letter for Its MiniMed 600 insulin pump, which I highlighted in an earlier article.

The recent boost is partly due to Medtronic's newest insulin pump, the MiniMed 780G ... There will continue to be a dire need for products that help simplify the lives of these patients.

That includes the MiniMed ... performance in products from cardiac pacing therapies, cardiac surgery, defibrillation solutions, and coronary solutions. In terms of guidance, Medtronic now expects ...

MDT stock breaking above its 200 and 50-day SMAs can be a piece of good news for investors, signaling an uptrend.

In the diabetes market, Medtronic plc (NYSE:MDT) has its MiniMed 780G detection algorithm, which simplifies diabetes management by automatically adjusting insulin delivery every five minutes. These ...

Specifically, Medtronic's diabetes and neuromodulation products may be poised for breakout ... was the firm's diabetes ...

Pharmac – Te Pātaka Whaioranga has decided to fund continuous glucose monitors (CGMs), insulin pumps, and insulin pump consumables for people with type 1 diabetes from 1 October 2024.